Sustained Post-Pandemic Demand: Post-COVID-19, global demand for disposable medical protective gowns (especially surgical gowns) remains high, driving growth in the nonwovens market. The market is expected to expand at a 6.2% compound annual growth rate (CAGR) by 2030.

Upgraded Infection Control Standards: Hospitals and healthcare facilities are increasing their demand for surgical gowns with higher levels of protection (e.g., AAMI Levels 3-4), driving the adoption of high-performance nonwovens (e.g., SMS structures). - Emerging Market Medical Infrastructure: The expansion of medical facilities in the Asia-Pacific, Middle East, and Africa regions is driving demand for surgical gowns, particularly in India and China (which account for over 40% of the Asia-Pacific market growth).

Combining Lightweight with High Protection: Companies are developing lighter, more breathable nonwoven fabrics (such as microfiber spunbond) that meet ASTM F1671 (blood penetration resistance) and ASTM F1670 (antiviral) standards.

The Rise of Sustainable Materials: The proportion of bio-based nonwovens (such as PLA) and recyclable materials is increasing, and EU regulations (such as the SUP Directive) are driving environmental transformation.

Antibacterial Coating Technology: Nonwoven fabrics infused with silver ions or copper-based antimicrobial agents are becoming a high-end product trend, reducing the risk of postoperative infection.

North America Dominates the Market (35% in 2025): Strict US FDA regulations and hospital procurement standards drive demand for high-quality nonwovens, giving companies like 3M and DuPont a technological advantage.

Europe Accelerates Green Transformation: Germany and France promote biodegradable surgical gowns, and the penetration rate of bio-based nonwovens in the EU is expected to reach 18% in 2025.

Intense Price Competition in Asia Pacific: Chinese manufacturers (such as the Berry Global joint venture) are gaining market share with low-cost SMS nonwovens, but the high-end market remains reliant on imports.

Consolidation of Leading Companies: The top five companies (Berry Global, Ahlstrom, Kimberly-Clark, etc.) control over 60% of the global market share and are expanding production capacity through mergers and acquisitions (such as Berry's acquisition of Freudenberg's medical division in 2024).

Localized Production Trend: To reduce transportation costs, multinational companies are setting up factories in India and Vietnam, shortening delivery times to regional hospitals.

Raw Material Price Fluctuations: PP (polypropylene) price fluctuations will impact profit margins in 2024, prompting companies to turn to recycled polypropylene to reduce costs.

--

5. Sustainability and Regulatory Challenges

Waste Management Pressure: Concerns about the medical waste generated by disposable surgical gowns are driving the development of reusable nonwovens (those sterilized 5-10 times).

Carbon Footprint Regulation: The EU Carbon Border Tax (CBAM) is forcing companies to adopt low-carbon production processes, such as energy-saving technologies in meltblown nonwoven production.

--

Future Outlook (2025-2030)

Smart Nonwovens: Technology that integrates sensors to monitor surgical gown damage or contamination is entering the pilot phase.

Customized Demand: Reinforced nonwoven products for obese patients or specialized surgeries (such as radiation protection) are experiencing significant growth.

Divergence in Price-Sensitive Markets: Emerging markets continue to focus on low-cost SMS, while high-end markets in Europe and the United States are focusing on composite film nonwovens (such as PE/PET multilayer structures).

Recommended: Companies need to balance protection performance with sustainability, monitor FDA/EU MDR regulatory updates, and establish localized supply chains in Asia Pacific to reduce costs.